PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
PharmaCyte Biotech, Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.34+0.00 (+0.53%)
Close on Oct 19, 2026
- Market cap
- $3.67M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of PharmaCyte Biotech's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2026 | Sep 14, 2026 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Apr 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2026 | Mar 17, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 30, 2026 | Mar 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 1, 2025 | Dec 5, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 31, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 30, 2025 | Oct 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2025 | Sep 15, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2025 | Aug 18, 2025 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2025 | Apr 24, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2025 | Mar 17, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 24, 2025 | Mar 10, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 21, 2025 | Feb 26, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2024 | Dec 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2024 | Sep 17, 2024 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 20, 2024 | May 23, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2024 | May 1, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2024 | Mar 27, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2024 | Mar 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Oct 31, 2023 | Dec 15, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2023 | Nov 24, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2023 | Nov 16, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2023 | Nov 9, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jul 31, 2023 | Sep 18, 2023 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2023 | Sep 7, 2023 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2023 | Aug 4, 2023 | SEC EDGAR |
| Annual report | 10-K | Apr 30, 2023 | Jul 31, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 31, 2023 | Jul 31, 2023 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2023 | Jul 19, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2023 | Jun 5, 2023 | SEC EDGAR |
| Current report | 8-K | May 9, 2023 | May 11, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jan 31, 2023 | Mar 16, 2023 | SEC EDGAR |
| Current report | 8-K | Jan 31, 2023 | Feb 2, 2023 | SEC EDGAR |
| Current report | 8-K | Dec 28, 2022 | Dec 30, 2022 | SEC EDGAR |